<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03204851</url>
  </required_header>
  <id_info>
    <org_study_id>16-08-1608</org_study_id>
    <nct_id>NCT03204851</nct_id>
  </id_info>
  <brief_title>Microlyte Dressing in the Management of Wounds</brief_title>
  <acronym>Microlyte</acronym>
  <official_title>An Open-Label Prospective Pilot Study to Evaluate the Efficacy and Tolerability of Microlyte Ag Pre-Dressing in the Management of Complex Skin Wounds.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mission Health System, Asheville, NC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imbed Biosciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mission Health System, Asheville, NC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to assess the efficacy of Microlyte Ag wound dressing when
      used in complex skin wounds. Microlyte Ag is a class-II medical device cleared by the FDA for
      prescription and over the counter use in humans. Primary clinical end point of study is
      percentage change in wound size from initiation of Microlyte Ag treatment through 90 days or
      until wound closure. Patient population comprises patients referred to Mission's Wound
      Healing and Hyperbaric Center for management of their wounds. Targeted enrollment is 100
      subjects distributed into 4 study cohorts corresponding to the type of wound treated: venous
      stasis ulcer (20 patients); diabetic foot ulcer [DFU] (20 patients); pressure ulcer (20
      patients); wounds of various other etiologies (40 patients).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2016</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage change in wound size from initiation of Microlyte Ag treatment through 90 days or until wound closure.</measure>
    <time_frame>90 days</time_frame>
    <description>Wound Healing</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Wound Heal</condition>
  <arm_group>
    <arm_group_label>Venous Stasis Ulcer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Venous Stasis Ulcer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure Ulcers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pressure Ulcers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic Foot Ulcers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diabetic Foot Ulcers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wounds from a variety of etiologies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wounds from a variety of etiologies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wound Healing</intervention_name>
    <description>Microlyte Ag is a class-II medical device cleared by the FDA for prescription and over the counter use in humans with skin wounds.</description>
    <arm_group_label>Venous Stasis Ulcer</arm_group_label>
    <arm_group_label>Pressure Ulcers</arm_group_label>
    <arm_group_label>Diabetic Foot Ulcers</arm_group_label>
    <arm_group_label>Wounds from a variety of etiologies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women â‰¥18 years of age, inclusive

          -  Venous stasis ulcer, DFU, pressure ulcer, or other wound sufficiently complex as to be
             referred to Clinical Investigators at Mission's Wound Care and Bariatric Center

          -  Patient must be competent to consent for self

        Exclusion Criteria:

          -  Patients younger than 18 years of age

          -  Women who are pregnant or nursing

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Shillinglaw, DO</last_name>
    <role>Study Chair</role>
    <affiliation>Mission Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tracy Nanney, RN</last_name>
    <phone>828-213-5593</phone>
    <email>Tracy.nanney@msj.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashley Boone, BS</last_name>
    <phone>828-213-3961</phone>
    <email>Ashley.boone@msj.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mission Health System</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Boone, BS</last_name>
      <phone>828-213-3961</phone>
      <email>ashley.boone@msj.org</email>
    </contact>
    <contact_backup>
      <last_name>Nicole Gunn, MA</last_name>
      <phone>828-213-7055</phone>
      <email>nicole.gunn@msj.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2017</study_first_submitted>
  <study_first_submitted_qc>June 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

